Legislators
Bills
Statements
Lobbying
Travel
- Bills
- S.1681
S.1681: A bill to require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services.
About This Bill
- This bill was introduced in the 115th Congress
- This bill is primarily about health
- Introduced July 31, 2017
- Latest Major Action July 31, 2017
Bill Sponsor
Bill Version
- Introduced in Senate - July 31, 2017
Bill Actions
Date | Description |
---|---|
July 31, 2017 |
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
|
July 31, 2017 |
Introduced in the Senate by Bernard Sanders (ID-Vt.) |